Recipient Vessels for Free Tissue Flaps in Advanced Oncologic Defects of the Midface and Scalp

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-01

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to compare the postoperative outcomes based on superficial temporal versus cervical recipient vessels for midface and scalp advanced oncologic defects using free tissue flap for reconstruction.

The main question it aims to answer is:

• Which recipient vessel is most suitable for performing microanastomosis using free flaps for advanced midface and scalp oncologic defect.

Participants will be undergo resection of advanced malignant tumors of the midface and scalp with subsequent oncological reconstruction using free tissue flap.

Researchers will compare two groups where those in whom superficial temporal vessels will be used as the recipient vessels (group A) and those in whom cervical vessels will be used as the recipient vessels (group B) to see if there is a recipient vessel who is most suitable for performing microanastomosis using free flaps for advanced midface and scalp oncologic defect.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Reconstruction of Cervical Lymphatic System During Head and Neck Squamous Cell Carcinoma Surgery

NCT06815705

Head and Neck Squamous Cell Carcinoma Lymphedema, Secondary Neck Lymph Dissection +1 more

NOT_YET_RECRUITING NA

A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer

NCT01111942

Head and Neck Cancer

TERMINATED EARLY_PHASE1

Organ Preservation in the Multispeciality Therapy of Stage II-IV Locally Advanced Head and Neck Cancer

NCT01187472

Head and Neck Cancer

COMPLETED

Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection

NCT02918955

Head and Neck Neoplasms

COMPLETED PHASE3

Calcium Electroporation for Head and Neck Cancer

NCT03051269

Head Neck Cancer

UNKNOWN PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Advanced oncologic defects of the midface and scalp are a significant challenge to the reconstructive head neck surgeon, who must consider the need for midfacial projection, rehabilitation, and function restoration. Free flaps reconstruction in the midface and scalp region are the gold standard for advanced cases. There is no consensus in the literature on which recipient vessel is most suitable for performing microanastomosis using free flaps for advanced midface and scalp oncologic defect. The aim of this clinical trial is prospectively compare the results of microvascular flap reconstruction of midface and scalp advanced oncologic defects using superficial temporal versus cervical as recipient vessels. This is a parallel trial with permuted block randomization of patients who will be undergone a midface and scalp oncologic reconstruction with free tissue flap. Two groups will be analyzed: those in whom superficial temporal vessels will be used as the recipient vessels (group A) and those in whom cervical vessels will be used as the recipient vessels (group B). Allocation ratio will de 1:1 participants. Patient gender and age, cause and localization of the defect, flap choice for reconstruction, recipient vessels, intraoperative outcome, postoperative course, and complications were recorded and analyzed. Considering that this is a disease with rare staging, the calculated sample size was 26, but it will be increased by 30% (total of 34 participants who will be selected) since the death rate of these patients ranges from 8-25% A Fisher's exact test will be used to compare outcomes between the 2 groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Head Neck Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Parallel group trial design with allocation ratio of 1:1 and permuted block randomization

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

The care provider knows the surgical intervention and the randomized participant doesn´t know the recipient vessel performed

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Superficial temporal recipient vessels (group A)

Participants in whom superficial temporal vessels were used as the recipient vessels.

Group Type EXPERIMENTAL

Recipient vessel selected for microanastomosis

Intervention Type PROCEDURE

Free tissue flaps harvesting and microanastomosis were performed by the same surgeon and in a similar way in both group. Postoperative course, and complications were recorded and analyzed.

Cervical recipient vessels (group B)

Participants in whom cervical vessels were used as the recipient vessels.

Group Type ACTIVE_COMPARATOR

Recipient vessel selected for microanastomosis

Intervention Type PROCEDURE

Free tissue flaps harvesting and microanastomosis were performed by the same surgeon and in a similar way in both group. Postoperative course, and complications were recorded and analyzed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Recipient vessel selected for microanastomosis

Free tissue flaps harvesting and microanastomosis were performed by the same surgeon and in a similar way in both group. Postoperative course, and complications were recorded and analyzed.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients submitted to subtotal, total, or extensive radical oncologic maxillectomy, or advanced scalp oncologic defect
* Complete medical records for at least 30 days after the intervention
* Patients eligible for microanastomosis in both cervical and superficial temporal recipient vessels

Exclusion Criteria

* Pregnancy or breastfeeding;
* Serious diseases (sepsis, renal and hepatic failure, severe cardiovascular diseases, chronic obstructive pulmonary disease);
* Patients with HIV (human immunodeficiency virus) with or without AIDS (acquired immunodeficiency syndrome);
* Patients with synchronous malignant neoplasms of the upper airway-digestive tract;
* Patients who died within a period of less than 30 days or who were lost to follow-up for the same period

Minimum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No